We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+14.29%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.45B
AUM Growth
+$519M
Cap. Flow
-$25.5M
Cap. Flow %
-1.04%
Top 10 Hldgs %
32.76%
Holding
158
New
53
Increased
22
Reduced
25
Closed
33

Top Buys

Rank Stock Value
1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$90.2M
2
LH icon
Labcorp
LH
+$65.9M
3
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$53.4M
4
ABBV icon
AbbVie
ABBV
+$51.8M
5
ITMN
INTERMUNE INC
ITMN
+$35.3M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$43.2M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$41.1M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$37.6M
4
GMED icon
Globus Medical
GMED
+$34.2M
5
QCOR
QUESTCOR PHARMA INC
QCOR
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.78%
2 Technology 1.21%
3 Financials 0.56%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
1
CALL
Humana
HUM
$48B
$144M 5.89%
1,280,000
+1,000,000
+357% +$104M
AVDL
2
DELISTED
Avadel Pharmaceuticals
AVDL
$70.5M 2.88%
5,258,475
+925,000
+21% +$9.91M
AUXL
3
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$69.8M 2.85%
2,566,705
-1,546,680
-38% -$41.1M
LH icon
4
Labcorp
LH
$23.2B
$69.7M 2.85%
+826,078
New +$65.9M
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$68.6M 2.8%
+2,428,569
New +$90.2M
QCOR
6
DELISTED
QUESTCOR PHARMA INC
QCOR
$67.5M 2.76%
1,039,865
-466,432
-31% -$29.8M
ASPX
7
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$61.2M 2.5%
+1,988,990
New +$53.4M
ARRY
8
DELISTED
Array Biopharma Inc
ARRY
$57.4M 2.34%
12,205,673
+970,267
+9% +$4.88M
ITMN
9
DELISTED
INTERMUNE INC
ITMN
$53M 2.16%
+1,583,942
New +$35.3M
INFI
10
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$52.8M 2.16%
4,444,027
+462,284
+12% +$6.2M
ABBV icon
11
AbbVie
ABBV
$450B
$52.7M 2.15%
+1,025,000
New +$51.8M
QCOR
12
CALL
DELISTED
QUESTCOR PHARMA INC
QCOR
$48.7M 1.99%
750,000
+250,000
+50% +$16M
NXTM
13
DELISTED
NxStage Medical Inc.
NXTM
$48.4M 1.98%
3,801,175
-1,769,464
-32% -$23.1M
INSM icon
14
Insmed
INSM
$23.5B
$38.4M 1.57%
2,016,147
+963,902
+92% +$18.3M
DYAX
15
DELISTED
DYAX CORPORATION
DYAX
$34M 1.39%
3,786,478
+428,731
+13% +$3.9M
BDSI
16
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$33.6M 1.37%
3,986,760
+2,226,035
+126% +$18M
ITMN
17
CALL
DELISTED
INTERMUNE INC
ITMN
$33.5M 1.37%
+1,000,000
New +$22.3M
ATRS
18
DELISTED
Antares Pharma, Inc.
ATRS
$33.2M 1.36%
9,488,461
-652,713
-6% -$2.9M
TRNX
19
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$33M 1.35%
1,554,075
+44,101
+3% +$856K
UAM
20
DELISTED
Universal American Corp
UAM
$32.5M 1.33%
4,600,993
+301
+0% +$2.13K
AIRM
21
DELISTED
Air Methods Corp
AIRM
$29.5M 1.21%
552,544
+307,252
+125% +$16.4M
PACB icon
22
Pacific Biosciences
PACB
$447M
$28.9M 1.18%
5,406,110
+1,054,848
+24% +$6.67M
MCK icon
23
McKesson
MCK
$98.5B
$28.8M 1.18%
+163,000
New +$28.5M
MDT icon
24
Medtronic
MDT
$106B
$28.6M 1.17%
+464,000
New +$27M
MRK icon
25
Merck
MRK
$315B
$27.1M 1.11%
500,106
-259,694
-34% -$13.4M
1
2 3 4 5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q1 2014 Portfolio in Review

As of Q1 2014, Deerfield Management held 158 positions worth $2.45B, up 27% from $1.93B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Deerfield Management's Q1 2014 filing shows 53 new, 22 increased, 25 reduced and 33 closed positions. Its largest new stake was Dicerna Pharmaceuticals, Inc.: 2,428,569 shares worth $68.6M. The largest sale was Humana, an estimated $43.2M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Technology and Financials.

  • Deerfield Management's largest Q1 2014 buy was Dicerna Pharmaceuticals, Inc.: 2,428,569 shares worth $68.6M.
  • Deerfield Management added most to Insmed in Q1 2014, an estimated $18.3M increase.
  • Deerfield Management's biggest Q1 2014 reduction was AUXILIUM PHARAMCEUTICALS INC, cutting an estimated $41.1M.
  • Deerfield Management fully exited Humana in Q1 2014, selling an estimated $43.2M.
  • Deerfield Management's ten largest holdings make up 33% of its $2.45B portfolio in Q1 2014.
  • Deerfield Management opened 53 new positions and closed 33 in Q1 2014.
  • Deerfield Management's portfolio value rose 27% quarter-over-quarter to $2.45B.

Based on Deerfield Management's 13F filing for Q1 2014, filed 15 May 2014.